Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

Informations projet

COMBACTE-CDI

N° de convention de subvention: 777362

DOI

10.3030/777362

Projet clôturé

Date de signature de la CE 27 Octobre 2017

Date de début 1 Novembre 2017

Date de fin 30 Avril 2021

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total

€ 4 179 307,00

Contribution de l’UE

€ 2 312 305,00

Coordonné par

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (14)

Report on cost/benefit analysis
Results of the cost exercise
Report on heterogeneity of testing and delivery of dataset
Report on status of posting results

Report on the status of posting results in the study registry/ies (including timelines when final posting of results is scheduled after end of funding period).

Report on current guidelines for diagnosis, management and control of CDI
Report on high risk groups and delivery of dataset
Report to map stakeholders and their potential role in COMBACTE-CDI
Report on strain distribution and delivery of dataset
Full ethical approval of final study protocol from all countries
Delivery of completed transmission model
Report on current treatment pathways
Proposal of governance of a pan-European network to study CDI
Report on recurrent CDI, morbidity and mortality and delivery of dataset
Report on current surveillance practices

Websites, patent fillings, videos etc. (1)

Adaptation of COMBACTE website to include COMBACTE-CDI

Publications

Peer reviewed articles (1)

Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile

Auteurs: Ilse M Boekhoud, Igor Sidorov, Sam Nooij, Céline Harmanus, Ingrid M J G Bos-Sanders, Virginie Viprey, William Spittal, Emma Clark, Kerrie Davies, Jane Freeman, Ed J Kuijper, Wiep Klaas Smits, Marc Bonten, Kerrie A Davies, Ed J Kuijper, Maja Rupnik, Sebastian Wingen-Heiman, Evelina Tacconelli, Tuba Wilken, Nicolla Petrosillo, Marc Bonten, Philippe Cleuziat, Chris Webber, Mark Wilcox
Publié dans: Journal of Antimicrobial Chemotherapy, 2021, ISSN 0305-7453
Éditeur: Oxford University Press
DOI: 10.1093/jac/dkab097